Neoadjuvant docetaxel followed by radical prostatectomy in patients with high-risk localized prostate cancer: A preliminary report

被引：33
|
作者：
Oh, WK [1 ]
George, DJ
Kaufman, DS
Moss, K
Smith, MR
Richie, JP
Kantoff, PW
机构：
[1] Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Dept Adult Oncol, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Dept Adult Oncol, Boston, MA 02114 USA
[3] Brigham & Womens Hosp, Div Urol Surg, Boston, MA 02115 USA
[4] Dana Farber Canc Inst, Div Urol Surg, Boston, MA 02115 USA
来源：
SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 04期
关键词：
D O I：
10.1016/S0093-7754(01)90153-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：40 / 44
页数：5
相关论文
共 50 条
  • [31] Radical Prostatectomy for High-risk Prostate Cancer
    Karnes, R. Jeffrey
    Hatano, Tadashi
    Blute, Michael L.
    Myers, Robert P.
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (01) : 3 - 9
  • [32] SURGICAL OUTCOMES OF NEOADJUVANT DOCETAXEL CHEMOTHERAPY COMPARED WITH RADICAL PROSTATECTOMY ALONE IN PATIENTS WITH HIGH RISK PROSTATE CANCER
    Kang, Taejin
    Kim, Wansuk
    Lee, Jungmin
    Song, Cheryn
    Kim, Jun Hyuk Hong Choung-Soo
    Seoul, Ahn
    [J]. JOURNAL OF UROLOGY, 2010, 183 (04): : E230 - E230
  • [33] Radical prostatectomy in high-risk prostate cancer
    Ischia, Joseph
    Gleave, Martin
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2013, 20 (03) : 290 - 300
  • [34] Phase II trial of weekly docetaxel and complete androgen blockade prior to radical prostatectomy in high-risk localized prostate cancer patients
    Font, Albert
    Mellado, Begona
    Aparicio, Luis A.
    Gallardo, Enrique
    Mel, Ramon
    Alcaraz, Antonio
    Areal, Juan
    Gomez Veiga, Francisco J.
    Hannaoui, Nahim
    Gascon, Pere
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 146 - 146
  • [35] Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution
    Naoki Fujita
    Takuya Koie
    Chikara Ohyama
    Yoshimi Tanaka
    Osamu Soma
    Teppei Matsumoto
    Hayato Yamamoto
    Atsushi Imai
    Yuki Tobisawa
    Tohru Yoneyama
    Shingo Hatakeyama
    Yasuhiro Hashimoto
    [J]. International Journal of Clinical Oncology, 2017, 22 : 1087 - 1093
  • [36] Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution
    Fujita, Naoki
    Koie, Takuya
    Ohyama, Chikara
    Tanaka, Yoshimi
    Soma, Osamu
    Matsumoto, Teppei
    Yamamoto, Hayato
    Imai, Atsushi
    Tobisawa, Yuki
    Yoneyama, Tohru
    Hatakeyama, Shingo
    Hashimoto, Yasuhiro
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (06) : 1087 - 1093
  • [37] OUTCOMES OF NEOADJUVANT CHEMOHORMONAL THERAPY WITH COMPLETE ANDROGEN BLOCKADE, FOLLOWED BY TREATMENT WITH DOCETAXEL AND ESTRAMUSTINE PHOSPHATE BEFORE RADICAL PROSTATECTOMY IN PATIENTS WITH HIGH-RISK LOCALIZED PROSTATE CANCER: A PROPENSITY-SCORE MATCHING ANALYSIS
    Narita, Shintaro
    Sato, Hiromi
    Kobayashi, Mizuki
    Kikuchi, Akane
    Nara, Taketoshi
    Kanda, Sohei
    Numakura, Kazuyuki
    Koizumi, Atsushi
    Yamamoto, Ryuhei
    Saito, Mitsuru
    Inoue, Takamitsu
    Satoh, Shigeru
    Mitsuzuka, Koji
    Tsuchiya, Norihiko
    Ohyama, Chikara
    Arai, Yoichi
    Nanjo, Hiroshi
    Habuchi, Tomonori
    [J]. JOURNAL OF UROLOGY, 2020, 203 : E1133 - E1133
  • [38] Phase I study of weekly mitoxantrone and docetaxel before prostatectomy in patients with high-risk localized prostate cancer
    Beer, TM
    Garzotto, M
    Lowe, BA
    Ellis, WJ
    Montalto, MA
    Lange, PH
    Higano, CS
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (04) : 1306 - 1311
  • [39] Neoadjuvant therapy for high-risk localized prostate cancer
    Evan Y. Yu
    William K. Oh
    [J]. Current Oncology Reports, 2003, 5 (3) : 250 - 257
  • [40] Multicenter phase II study of combined neoadjuvant docetaxel and hormone therapy before radical prostatectomy for patients with high risk localized prostate cancer - Comment
    Mohler, James L.
    [J]. JOURNAL OF UROLOGY, 2008, 180 (02): : 570 - 570
12345